important. Recent literature suggests concurrent in utero exposure to opioid analgesics and psychotropic medications may increase risk of NAS. We examined the association of exposure to psychotropic medications with outcomes in women with opioid use disorders using medication assisted treatment with buprenorphine (B-MAT) STUDY DESIGN: A retrospective cohort study of 115 women on B-MAT was conducted: B-MAT exposure only v. B-MAT with mental health diagnoses v. B-MAT & psychotropic medication exposure within 45 days of delivery. Primary outcomes were rates of NAS requiring treatment and positive UDS at delivery (non-prescribed substances). Secondary outcomes included gestational age at care initiation, postpartum care, newborn size, & length of stay (LOS). Chi square & Kruskal-Wallis analyses were performed (p>0.05). RESULTS: Compared to infants exposed only to B-MAT, the other cohorts had double the rates of NAS; this trend was not significant (p¼0.054; see Tables 1 & 2) . Positive UDS was not significantly different (p¼0.098). No differences were noted in newborn size or LOS. Dually diagnosed women, treated with psychotropics or not, were more likely to begin care in the first trimester; those treated with psychotropics were more likely to attend postpartum visits. CONCLUSION: Our findings are limited by sample size but suggest maternal and fetal outcomes are similar among women with concurrent opioid use disorder and mental health diagnoses whether treated with psychotropic medications or not.
Poster Session II Patients who had gradual balloon deflation (30 minutes from start of deflation to removal) were compared to those who had the balloon deflated and removed all-at-once. Clinical outcomes were assessed including estimated blood loss (EBL), decrease in hemoglobin, blood transfusion, need for additional invasive surgical procedures (i.e. uterine artery embolization, B-Lynch, hysterectomy), ICU admission and postpartum fever. The primary study outcome was a composite maternal morbidity of transfusion 4 units PRBC, disseminated intravascular coagulopathy (DIC), need for additional invasive surgical procedures or ICU admission. Chi-square, Mann Whitney U and multivariate logistic regression models were used for statistical analysis. RESULTS: Of 51 women with PPH and intrauterine balloon placement, 40 (78.4%) underwent gradual balloon deflation and 11 (21.6%) underwent all-at-once removal. The median duration of intrauterine balloon tamponade was 1100 minutes (150-2025 minutes), and did not differ between the two groups (1090 vs 1230 minutes, p¼0.95). Within the gradual group, the median time from start of deflation to complete balloon removal was 150 minutes (30-510 minutes). Clinical outcomes are shown in the Table. Composite maternal morbidity was not statistically different between the gradual and all-at-once groups (25% vs 27.3%, p¼0.88). Maternal age, parity, gestational age, BMI, mode of delivery, and neonatal weights did not differ between the two groups. The groups had similar rates of inductions, cesarean deliveries, multifetal pregnancies, episiotomies and postpartum fevers. There were no peripartum hysterectomies or maternal deaths. CONCLUSION: In women with refractory PPH requiring intrauterine balloon tamponade, gradual balloon deflation compared to all-atonce removal have similar clinical outcomes.
323 Pregnancy outcomes in women with an incidentally detected unicornuate uterus OBJECTIVE: Unicornuate uterus is associated with complications such as cervical insufficiency, pregnancy loss, spontaneous preterm birth and FGR. A limitation of existing data is that imaging is more likely to be done in women with poor obstetrical outcomes, which identifies a group at higher risk for complications in subsequent pregnancies. The objective of this study was to assess pregnancy outcomes in women with an incidentally detected unicornuate uterus. STUDY DESIGN: Retrospective review of an obstetrical database from 2005-2017 identified women with unicornuate uteri at 12 weeks. Diagnoses were made with imaging studies (HSG or MRI) during
